NEW!
BASIC AND CLINICAL PHARMACOLOGY 15TH EDITION
nB nB nB nB nB
KATZUNG TREVOR TEST BANK
nB nB nB nB
, Page nB2 nBof nB822
Basic and Clinical Pharmacology 15th Edition Katzung Trevor Test
nB nB nB nB nB nB nB nB
Bank
n B
Chapter nB1. nBIntroduction: nBThe nBNature nBof nBDrugs nB& nBDrug nBDevelopment nB& nBRegulation
1. A nBnurse nBworking nBin nBradiology nBadministers nBiodine nBto nBa nBpatient nBwho nBis
nBhaving nBa nBcomputed nBtomography nB(CT) nBscan. nBThe nBnurse nBworking nBon
nBthe nBoncology nBunit nBadministers nBchemotherapy nBto nBpatients nBwho nBhave
nBcancer. nBAt nBthe nBPublic nBHealth nBDepartment, nBa nBnurse nBadministers nBa
nBmeasles-mumps-rubella nB(MMR) nBvaccine nBto nBa nB14-month-old nBchild nBas nBa
nBroutine nBimmunization. nBWhich nBbranch nBof nBpharmacology nBbest nBdescribes
nBthe nBactions nBof nBall nBthree n B nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
Pharmacology nBis nBthe nBstudy nBof nBthe nBbiologic nBeffects nBof nBchemicals.
nBNurses nBare nBinvolved nBwith nBclinical nBpharmacology nBor
nBpharmacotherapeutics, nBwhich nBis nBa nBbranch nBof nBpharmacology nBthat nBdeals
nBwith nBthe nBuses nBof nBdrugs nBto nBtreat, nBprevent, nBand nBdiagnose nBdisease. nBThe
nBradiology nBnurse nBis nBadministering nBa nBdrug nBto nBhelp nBdiagnose nBa nBdisease.
nBThe nBoncology nBnurse nBis nBadministering nBa nBdrug nBto nBhelp nBtreat nBa nBdisease.
nBPharmacoeconomics nBincludes nBany nBcosts nBinvolved nBin nBdrug nBtherapy.
Pharmacodynamics nBinvolves nBhow nBa nBdrug nBaffects nBthe nBbody nBand
nBpharmacokinetics nBis nBhow nBthe nBbody nBacts nBon nBthe nBbody.
2. When nBinvolved nBin nBphase nBIII nBdrug nBevaluation nBstudies,
nBwhat nBresponsibilities nBwould nBthe nBnurse nBhave?
A) Working nBwith nBanimals nBwho nBare nBgiven nBexperimental n B drugs
B) Choosing nBappropriate nBpatients nBto nBbe nBinvolved nBin nBthe nBdrug n B study
C) Monitoring nBand nBobserving nBpatients nBclosely nBfor nBadverse n B effects
D) Conducting nBresearch nBto nBdetermine nBeffectiveness nBof nBthe n B drug
, Page nB3 nBof nB822
Ans: C
Feedback:
Phase nBIII nBstudies nBinvolve nBuse nBof nBa nBdrug nBin nBa nBvast nBclinical nBpopulation
nBin nBwhich nBpatients nBare nBasked nBto nBrecord nBany nBsymptoms nBthey
nBexperience nBwhile nBtaking nBthe nBdrugs. nBNurses nBmay nBbe nBresponsible nBfor
nBhelping nBcollect nBand nBanalyze nBthe nBinformation nBto nBbe nBshared nBwith nBthe
nBFood nBand nBDrug nBAdministration nB(FDA) nBbut nBwould nBnot nBconduct
nBresearch nBindependently nBbecause nBnurses nBdo nBnot nBprescribe nBmedications.
nBUse nBof nBanimals nBin nBdrug nBtesting nBis nBdone nBin nBthe nBpreclinical nBtrials.
nBSelect nBpatients nBwho nBare nBinvolved nBin nBphase nBII nBstudies nBto nBparticipate
nBin nBstudies nBwhere nBthe nBparticipants nBhave nBthe nBdisease nBthe nBdrug nBis
nBintended nBto nBtreat. nBThese nBpatients nBare nBmonitored nBclosely nBfor nBdrug
nBaction nBand nBadverse nBeffects. nBPhase nBI nBstudies nBinvolve nBhealthy nBhuman
nBvolunteers nBwho nBare nBusually nBpaid nBfor nBtheir nBparticipation. nBNurses nBmay
nBobserve nBfor nBadverse nBeffects nBand nBtoxicity.
3. A nBphysician nBhas nBordered nBintramuscular nB(IM) nBinjections nBof nBmorphine,
nBa nBnarcotic, nBevery nB4 nBhours nBas nBneeded nBfor nBpain nBin nBa nBmotor nBvehicle
nBaccident nBvictim. nBThe nBnurse nBis nBaware nBthis nBdrug nBhas nBa nBhigh nBabuse
nBpotential. nBUnder nBwhat nBcategory nBwould nBmorphine nBbe nBclassified?
A) Schedule nBI
B) Schedule nBII
C) Schedule nBIII
D) Schedule nBIV
Ans: B
Feedback:
Narcotics nBwith nBa nBhigh nBabuse nBpotential nBare nBclassified nBas nBSchedule nBII
nBdrugs nBbecause nBof nBsevere nBdependence nBliability. nBSchedule nBI nBdrugs
nBhave nBhigh nBabuse nBpotential nBand nBno nBaccepted nBmedical nBuse. nBSchedule
nBIII nBdrugs nBhave nBa nBlesser nBabuse nBpotential nBthan nBII nBand nBan nBaccepted
nBmedical nBuse. nBSchedule nBIV nBdrugs nBhave nBlow nBabuse nBpotential nBand
nBlimited nBdependence nBliability.
4. What nBconcept nBis nBconsidered nBwhen nBgeneric nBdrugs nBare nBsubstituted nBfor
nBbrand nBname nBdrugs?
A) Bioavailability
, WWW.THENURSINGMASTERY.
www.stuvia.com
BASIC AND CLINICAL PHARMACOLOGY 15TH EDITION
nB nB nB nB nB
KATZUNG TREVOR TEST BANK
nB nB nB nB
, Page nB2 nBof nB822
Basic and Clinical Pharmacology 15th Edition Katzung Trevor Test
nB nB nB nB nB nB nB nB
Bank
n B
Chapter nB1. nBIntroduction: nBThe nBNature nBof nBDrugs nB& nBDrug nBDevelopment nB& nBRegulation
1. A nBnurse nBworking nBin nBradiology nBadministers nBiodine nBto nBa nBpatient nBwho nBis
nBhaving nBa nBcomputed nBtomography nB(CT) nBscan. nBThe nBnurse nBworking nBon
nBthe nBoncology nBunit nBadministers nBchemotherapy nBto nBpatients nBwho nBhave
nBcancer. nBAt nBthe nBPublic nBHealth nBDepartment, nBa nBnurse nBadministers nBa
nBmeasles-mumps-rubella nB(MMR) nBvaccine nBto nBa nB14-month-old nBchild nBas nBa
nBroutine nBimmunization. nBWhich nBbranch nBof nBpharmacology nBbest nBdescribes
nBthe nBactions nBof nBall nBthree n B nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
Pharmacology nBis nBthe nBstudy nBof nBthe nBbiologic nBeffects nBof nBchemicals.
nBNurses nBare nBinvolved nBwith nBclinical nBpharmacology nBor
nBpharmacotherapeutics, nBwhich nBis nBa nBbranch nBof nBpharmacology nBthat nBdeals
nBwith nBthe nBuses nBof nBdrugs nBto nBtreat, nBprevent, nBand nBdiagnose nBdisease. nBThe
nBradiology nBnurse nBis nBadministering nBa nBdrug nBto nBhelp nBdiagnose nBa nBdisease.
nBThe nBoncology nBnurse nBis nBadministering nBa nBdrug nBto nBhelp nBtreat nBa nBdisease.
nBPharmacoeconomics nBincludes nBany nBcosts nBinvolved nBin nBdrug nBtherapy.
Pharmacodynamics nBinvolves nBhow nBa nBdrug nBaffects nBthe nBbody nBand
nBpharmacokinetics nBis nBhow nBthe nBbody nBacts nBon nBthe nBbody.
2. When nBinvolved nBin nBphase nBIII nBdrug nBevaluation nBstudies,
nBwhat nBresponsibilities nBwould nBthe nBnurse nBhave?
A) Working nBwith nBanimals nBwho nBare nBgiven nBexperimental n B drugs
B) Choosing nBappropriate nBpatients nBto nBbe nBinvolved nBin nBthe nBdrug n B study
C) Monitoring nBand nBobserving nBpatients nBclosely nBfor nBadverse n B effects
D) Conducting nBresearch nBto nBdetermine nBeffectiveness nBof nBthe n B drug
, Page nB3 nBof nB822
Ans: C
Feedback:
Phase nBIII nBstudies nBinvolve nBuse nBof nBa nBdrug nBin nBa nBvast nBclinical nBpopulation
nBin nBwhich nBpatients nBare nBasked nBto nBrecord nBany nBsymptoms nBthey
nBexperience nBwhile nBtaking nBthe nBdrugs. nBNurses nBmay nBbe nBresponsible nBfor
nBhelping nBcollect nBand nBanalyze nBthe nBinformation nBto nBbe nBshared nBwith nBthe
nBFood nBand nBDrug nBAdministration nB(FDA) nBbut nBwould nBnot nBconduct
nBresearch nBindependently nBbecause nBnurses nBdo nBnot nBprescribe nBmedications.
nBUse nBof nBanimals nBin nBdrug nBtesting nBis nBdone nBin nBthe nBpreclinical nBtrials.
nBSelect nBpatients nBwho nBare nBinvolved nBin nBphase nBII nBstudies nBto nBparticipate
nBin nBstudies nBwhere nBthe nBparticipants nBhave nBthe nBdisease nBthe nBdrug nBis
nBintended nBto nBtreat. nBThese nBpatients nBare nBmonitored nBclosely nBfor nBdrug
nBaction nBand nBadverse nBeffects. nBPhase nBI nBstudies nBinvolve nBhealthy nBhuman
nBvolunteers nBwho nBare nBusually nBpaid nBfor nBtheir nBparticipation. nBNurses nBmay
nBobserve nBfor nBadverse nBeffects nBand nBtoxicity.
3. A nBphysician nBhas nBordered nBintramuscular nB(IM) nBinjections nBof nBmorphine,
nBa nBnarcotic, nBevery nB4 nBhours nBas nBneeded nBfor nBpain nBin nBa nBmotor nBvehicle
nBaccident nBvictim. nBThe nBnurse nBis nBaware nBthis nBdrug nBhas nBa nBhigh nBabuse
nBpotential. nBUnder nBwhat nBcategory nBwould nBmorphine nBbe nBclassified?
A) Schedule nBI
B) Schedule nBII
C) Schedule nBIII
D) Schedule nBIV
Ans: B
Feedback:
Narcotics nBwith nBa nBhigh nBabuse nBpotential nBare nBclassified nBas nBSchedule nBII
nBdrugs nBbecause nBof nBsevere nBdependence nBliability. nBSchedule nBI nBdrugs
nBhave nBhigh nBabuse nBpotential nBand nBno nBaccepted nBmedical nBuse. nBSchedule
nBIII nBdrugs nBhave nBa nBlesser nBabuse nBpotential nBthan nBII nBand nBan nBaccepted
nBmedical nBuse. nBSchedule nBIV nBdrugs nBhave nBlow nBabuse nBpotential nBand
nBlimited nBdependence nBliability.
4. What nBconcept nBis nBconsidered nBwhen nBgeneric nBdrugs nBare nBsubstituted nBfor
nBbrand nBname nBdrugs?
A) Bioavailability
, WWW.THENURSINGMASTERY.
www.stuvia.com
